Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Data from The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells
View through CrossRef
<div>Abstract<p><b>Purpose:</b> Activation of the c-Met and epidermal growth factor receptors (EGFR) promotes the growth and survival of non–small cell lung cancer (NSCLC). Specific receptor antagonists have shown efficacy in the clinic, but tumors often become resistant to these therapies. We investigated the ability of (-)-epigallocatechin-3-gallate (EGCG) to inhibit cell proliferation, and c-Met receptor and EGFR kinase activation in several NSCLC cell lines.</p><p><b>Experimental Design:</b> NSCLC cell lines with variable sensitivity to the EGFR antagonist erlotinib were studied. Cell growth was evaluated using proliferation and colony formation assays. Kinase activation was assessed via Western blot analysis. Experiments were conducted with EGCG, the EGFR antagonist erlotinib, and the c-Met inhibitor SU11274. The antagonists were also tested in a xenograft model using SCID mice.</p><p><b>Results:</b> EGCG inhibited cell proliferation in erlotinib-sensitive and -resistant cell lines, including those with c-Met overexpression, and acquired resistance to erlotinib. The combination of erlotinib and EGCG resulted in greater inhibition of cell proliferation and colony formation than either agent alone. EGCG also completely inhibited ligand-induced c-Met phosphorylation and partially inhibited EGFR phosphorylation. The triple combination of EGCG/erlotinib/SU11274 resulted in a greater inhibition of proliferation than EGCG with erlotinib. Finally, the combination of EGCG and erlotinib significantly slowed the growth rate of H460 xenografts.</p><p><b>Conclusion:</b> EGCG is a potent inhibitor of cell proliferation, independent of EGFR inhibition, in several NSCLC cell lines, including those resistant to both EGFR kinase inhibitors and those overexpressing c-Met. Therefore, EGCG might be a useful agent to study as an adjunct to other anticancer agents.</p></div>
American Association for Cancer Research (AACR)
Title: Data from The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells
Description:
<div>Abstract<p><b>Purpose:</b> Activation of the c-Met and epidermal growth factor receptors (EGFR) promotes the growth and survival of non–small cell lung cancer (NSCLC).
Specific receptor antagonists have shown efficacy in the clinic, but tumors often become resistant to these therapies.
We investigated the ability of (-)-epigallocatechin-3-gallate (EGCG) to inhibit cell proliferation, and c-Met receptor and EGFR kinase activation in several NSCLC cell lines.
</p><p><b>Experimental Design:</b> NSCLC cell lines with variable sensitivity to the EGFR antagonist erlotinib were studied.
Cell growth was evaluated using proliferation and colony formation assays.
Kinase activation was assessed via Western blot analysis.
Experiments were conducted with EGCG, the EGFR antagonist erlotinib, and the c-Met inhibitor SU11274.
The antagonists were also tested in a xenograft model using SCID mice.
</p><p><b>Results:</b> EGCG inhibited cell proliferation in erlotinib-sensitive and -resistant cell lines, including those with c-Met overexpression, and acquired resistance to erlotinib.
The combination of erlotinib and EGCG resulted in greater inhibition of cell proliferation and colony formation than either agent alone.
EGCG also completely inhibited ligand-induced c-Met phosphorylation and partially inhibited EGFR phosphorylation.
The triple combination of EGCG/erlotinib/SU11274 resulted in a greater inhibition of proliferation than EGCG with erlotinib.
Finally, the combination of EGCG and erlotinib significantly slowed the growth rate of H460 xenografts.
</p><p><b>Conclusion:</b> EGCG is a potent inhibitor of cell proliferation, independent of EGFR inhibition, in several NSCLC cell lines, including those resistant to both EGFR kinase inhibitors and those overexpressing c-Met.
Therefore, EGCG might be a useful agent to study as an adjunct to other anticancer agents.
</p></div>.
Related Results
Einfluss von (‐)‐Epigallocatechin‐3‐gallat auf Enzyme der Klassen der Histondeacetylasen und Topoisomerasen in Zellmodellen
Einfluss von (‐)‐Epigallocatechin‐3‐gallat auf Enzyme der Klassen der Histondeacetylasen und Topoisomerasen in Zellmodellen
Zusammenfassung(‐)‐Epigallocatechin‐3‐gaNat (EGCG) gehört zu der Gruppe der Catechine, welche 30‐40 % der festen Bestandteile von grünem Tee ausmachen. Eine Vielzahl von gesundheit...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Data from The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells
Data from The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non–small Cell Lung Cancer Cells
<div>Abstract<p><b>Purpose:</b> Activation of the c-Met and epidermal growth factor receptors (EGFR) promotes the growth and survival of non–small cell lung...
In silico
and
in vitro
studies suggest epigallocatechin gallate (EGCG), a polyphenol in green tea, can bind and modulate the aggregation and cytotoxicity of the full-length TDP-43 protein implicated in
In silico
and
in vitro
studies suggest epigallocatechin gallate (EGCG), a polyphenol in green tea, can bind and modulate the aggregation and cytotoxicity of the full-length TDP-43 protein implicated in
ABSTRACT
Misfolding and aggregation of TDP-43 protein are implicated in several proteinopathies like ALS and FTLD. Extracellular TDP-43 is also p...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Data from The Heat Shock Protein 90 Inhibitor, (−)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model
Data from The Heat Shock Protein 90 Inhibitor, (−)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model
<div>Abstract<p>(−)-Epigallocatechin gallate (EGCG), a major tea polyphenol, elicits anticancer effects. However, the mechanism of action is not fully understood. Our l...
Data from The Heat Shock Protein 90 Inhibitor, (−)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model
Data from The Heat Shock Protein 90 Inhibitor, (−)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model
<div>Abstract<p>(−)-Epigallocatechin gallate (EGCG), a major tea polyphenol, elicits anticancer effects. However, the mechanism of action is not fully understood. Our l...
Mediating Effect of Tea Perception on the Relationship between Tea Amenity and Tea Life Satisfaction: A Study of University Students in Gimhae
Mediating Effect of Tea Perception on the Relationship between Tea Amenity and Tea Life Satisfaction: A Study of University Students in Gimhae
This study empirically investigated the effects of tea amenity—reflecting the environmental, cultural, social, and value characteristics of tea—and tea perception on tea life satis...